A carregar...
Anti‐EGFR antibody‐drug conjugate for triple‐negative breast cancer therapy
Triple‐negative breast cancers (TNBCs) are highly aggressive, metastatic and recurrent. Cytotoxic chemotherapies with limited clinical benefits and severe side effects are the standard therapeutic strategies, but, to date, there is no efficacious targeted therapy. Literature and our data showed that...
Na minha lista:
| Publicado no: | Eng Life Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837297/ https://ncbi.nlm.nih.gov/pubmed/33531889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/elsc.202000027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|